newsfilter
← Latest News
GlobeNewswire·

eFFECTOR Therapeutics to Present at Cantor Oncology, Hematology, HemeOnc Conference

SAN DIEGO and REDWOOD CITY, Calif., Sept. 21, 2022 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR), a leader in the development of selective translation regulator inhibitors ("STRIs") for the treatment of cancer, today announced that the